Message from the President August 2008Tuesday August 12 Dear Fellow CHLA Member,
I hope you are enjoying our summer so far in spite of a very rainy July and August!
The reason for my note is to make you aware of a couple of very important meetings which are occurring next month which you will no doubt want to mark off in your calendars.
1. 2008 ARCHITECTS OF ALLIANCES COURSE SEPT 10/11, 2008 IN TORONTO
The 2008 Architects of Alliances course is taking place in Toronto on September 10th and 11th at the University Club. For the registration information and agenda please visit the CHLA website: http://www.chlassoc.com . The course is all-new this year with a focus on the key issues involved in conducting due diligence.
Successful deal-making depends on an effective due diligence process. Whether you are buying or selling, effective due diligence is critical to understanding the project and partner to develop a better deal-making strategy and to strike a better deal that will maximize the value of the opportunity and begin a successful partnership. Today’s multi-functional due diligence often requires participation of many people within an organization (Finance, Medical, Marketing, Manufacturing, Quality Assurance, etc.) – and unless they have direct experience with due diligence there is little formal training available for them. The 2008 Architects of Alliances course has assembled an all-star faculty to share their experiences and provide instruction on conducting due diligence and how to use due diligence findings in negotiations and deal-making.
About the faculty -
• All are senior management, including 3 CEOs
• All highly experienced in deals, deal making and due diligence
• Representing A-List Companies who are in the news, Esperion, Nektar, OSI, etc.
• Experience at Big Pharma including Pfizer, Novartis, Lilly, etc.
• All have US experience, and many have international experience
• Speaker List:
o John Krayacich, Vice President Global Neuroscience Project Manager for Novartis, a major Pharma. Now CEO Marinus
o David McNaughton, Head of the Royalty Monetization Fund for DRI Capital Inc.,a Specialty Finance Company
o Carlo Di Fonzo, Vice President of Global Regulatory Affairs and Product Safety for Leading Drug Delivery Biotech, Nektar Therapeutics
o Wendy Hill, Leading Clinical Consultant, Managing Principal of Gap Strategies
o David Ghesquiere, Vice President Corporate and Business Development, for Leading Biotech, OSI Pharmaceuticals
o Roger Newton, CEO, Esperion Therapeutics
o Jon Daniels, Leading ToxicologyConsultant, Vice President, IntrinsikHealth Science.
o Calum Neish, Leading Consultant and Engagement Manager, IMS Health
o Brad Hossack, VP Intercontinental Division, Boston Scientific a Leading Medical Device Company
o Diane Kalina, CEO PDC Biotech
o Eileen McMahon, Partner Tory’s
o Dan Vickery, President, BioEnsemble
Please register today to ensure your spot since registration is limited – and forward to others within your organization that may be interested. As a CHLA-accredited course there is a discount for anyone from a CHLA member company and there is a discount for multiple registrations from the same company.
2. CHLA FALL MEETING 2008
Revving Up Growth Engines with Biotech: Exploring European & Canadian Opportunities in Lifesciences
Location: Cercle de la Garnison, Quebec City
Date: Tuesday, September 30th, 6-9PM
This event will be taking place during BioContact in Quebec City. Both the Belgian and the French Consulates are participating and speakers from BIO clusters (Biowin and Alsace Biovalley) will present their cluster, research area, member companies, etc. The following presentations are already confirmed:
Belgium:
• Pierre NOKIN, Director of BIOWIN http://www.biowin.org , a biotech cluster. Pierre will make a short presentation on biotech company members of the BIOWIN cluster.
• Philippe JANSSENS De VAREBEKE, from the consulate will talk about the Wallonie as an investment ground in the biomédical and biopharmaceutical area.
France
• Nicolas Carboni, Director of ALSACE BIOVALLEY http://www.alsace-biovalley.com will be presenting a few biotech company members of the cluster.
On behalf of the entire CHLA Organizing Committee I sincerely hope that you can attend both the 2008 Architects of Alliances and the CHLA Fall Meeting.
Sincerely,
Neil Mellor
CHLA President
____________________________________
BACK TO TOP |